tiprankstipranks
Clariant AG (DE:CLRN)
FRANKFURT:CLRN
Germany Market

Clariant AG (CLRN) Earnings Dates, Call Summary & Reports

Compare
1 Followers

Earnings Data

Report Date
May 08, 2026
TBA (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
Last Year’s EPS
0
Same Quarter Last Year
Based on 6 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 26, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed a largely positive operational and financial performance for FY2025: Clariant delivered improved profitability (EBITDA +5%, +180 bps margin), substantially stronger cash conversion (42%, +10 ppt), progress on the CHF 80m savings program (CHF 50m achieved), and notable sustainability and customer/employee engagement improvements. These positives were partially offset by modest volume declines, currency headwinds, the underperformance of Adsorbents & Additives, working capital build-up, ongoing macroeconomic uncertainty, and litigation risk. Management expects 2026 sales roughly flat in local currency and modest margin progression to ~18% while highlighting persistent market and inflationary headwinds and that a fuller recovery in segments like Catalysts is likely conditional on broader market improvement in 2027+. Overall, the call signals that operational execution and cash generation are strong, but external demand and some segment-specific headwinds limit near-term upside.
Company Guidance
Clariant guided that 2026 sales in local currency should be around flat (addressable market growth ~1%) with a ~1% negative top‑line impact from prior‑year portfolio pruning; they expect slight underlying growth in Care Chemicals while Catalysts should be at levels similar to 2025. Management targets an EBITDA margin before exceptional items of around 18% (vs 17.8% in 2025 and a medium‑term target of 19–21%), expects the CHF 80m performance‑improvement program to deliver most remaining savings during 2026, and aims for free cash‑flow conversion of ~40% (after achieving 42% in 2025); they assume cost inflation of ~3–4% and cite macro assumptions of global GDP ~2.8%, chemical output growth ~1.9% (down from 2.9% in 2025), China slowing from 7.4% to 2.7%, the US turning to –0.6% (from +0.6%), and Europe improving to +0.5% (from –0.4%).
Improved Profitability
EBITDA before exceptional items increased 5% to CHF 679 million for FY2025; EBITDA margin before exceptional items improved by 180 basis points to 17.8% (from 16.0% in 2024). Q4 EBITDA before exceptional items rose 10% with a margin of 17.1% (+240 bps YoY).
Strong Cash Generation and Conversion
Free cash flow increased 31% to CHF 273 million and free cash flow conversion improved to 42%, a 10 percentage point increase versus 2024, already exceeding the medium-term 40% target.
Sales Stability in Tough Environment
Reported full-year sales were CHF 3.9 billion and flat in local currency despite a negative currency translation effect of approximately -6% for the year; Q4 sales were CHF 1.0 billion (+1% in local currency).
Progress on Cost Savings Program
Investor Day program run-rate target CHF 80 million by end-2027: CHF 50 million achieved in 2025 (63% of target), including CHF 19 million in Q4 and CHF 22 million from procurement initiatives; restructuring charges were CHF 63 million (below prior expectation of CHF 75 million).
Innovation and R&D Momentum
Innovation sales increased to 18.8% of revenue in 2025 (from 16.9% in 2024); R&D investment maintained at ~3% of revenue; innovation pipeline earned over 30 industry/customer awards.
Sustainability Leadership and Emissions Reductions
SBTi-approved targets: absolute Scope 1 & 2 emissions reduction target of 47% and Scope 3 reduction of 28% vs 2019 base. Scope 1 & 2 emissions fell 11% to 0.43 million metric tons; renewable electricity share rose from 69% to 76%; Scope 3.1 fell 6% to 2.4 million metric tons. Achieved top 1% CDP leadership with A in climate change and forests, A- in water security.
Customer and Employee Engagement Improvements
Customer Net Promoter Score (cNPS) rose to 50 from 45 (top-quartile vs peers). Employee Net Promoter Score (eNPS) increased to 37 from 34, employee participation 88% and engagement 87% (top quartile); safety improved with DART rate down to 0.13 from 0.17.
Segment-Level Outperformance (Catalysts & Care Chemicals)
Catalysts: Q4 sales +5% in local currency; EBITDA before exceptional items +22% to CHF 62 million, margin 23.4% (vs 18.8% prior). Care Chemicals: Q4 sales +1% LFL, EBITDA CHF 96 million (+7%), margin 18.3% (+220 bps).
Platform & Digital Adoption
CLARITY cloud-based catalyst management utilization nearly doubled to >220 customer plants and >800 users across 38 countries by end-2025, supporting customer operations and retention.
Shareholder Distribution
Proposing a stable distribution to shareholders of CHF 0.42 per share, reflecting confidence in cash generation and balance sheet management.

Clariant AG (DE:CLRN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DE:CLRN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 08, 2026
2026 (Q1)
- / -
0
Feb 26, 2026
2025 (Q4)
0.33 / 0.21
0.15735.42% (+0.06)
Oct 30, 2025
2025 (Q3)
0.00 / 0.00
0.492
Jul 31, 2025
2025 (Q2)
0.42 / 0.23
0.519-54.74% (-0.28)
Apr 29, 2025
2025 (Q1)
0.00 / 0.00
0
Feb 28, 2025
2024 (Q4)
0.45 / 0.16
0.263-40.25% (-0.11)
Oct 29, 2024
2024 (Q3)
0.00 / 0.00
0
Jul 30, 2024
2024 (Q2)
0.41 / 0.52
0.26198.74% (+0.26)
Apr 30, 2024
2024 (Q1)
0.00 / 0.00
0.212
Feb 29, 2024
2023 (Q4)
0.18 / 0.26
0.107145.92% (+0.16)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

DE:CLRN Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 26, 2026
€8.79€8.90+1.31%
Oct 30, 2025
€7.68€7.72+0.52%
Jul 31, 2025
€9.33€9.03-3.22%
Apr 29, 2025
€16.84€16.840.00%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Clariant AG (DE:CLRN) report earnings?
Clariant AG (DE:CLRN) is schdueled to report earning on May 08, 2026, TBA (Confirmed).
    What is Clariant AG (DE:CLRN) earnings time?
    Clariant AG (DE:CLRN) earnings time is at May 08, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Clariant AG stock?
          The P/E ratio of Clariant AG is N/A.
            What is DE:CLRN EPS forecast?
            Currently, no data Available